Evaluation of virucidal activity of fabrics using feline coronavirus.


Journal

Journal of virological methods
ISSN: 1879-0984
Titre abrégé: J Virol Methods
Pays: Netherlands
ID NLM: 8005839

Informations de publication

Date de publication:
09 2021
Historique:
received: 16 02 2021
accepted: 08 06 2021
pubmed: 13 6 2021
medline: 24 7 2021
entrez: 12 6 2021
Statut: ppublish

Résumé

Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2) is an enveloped RNA virus responsible for the 2019 coronavirus disease (COVID-19) that represents a global health threat, causing an ongoing pandemic in many countries and territories. WHO recommendations emphasize the importance of all personal protective equipment (PPE) that can interrupt COVID-19 transmission. The textile industry and scientists are developing hygienic fabrics by the addition of or treatment with various antimicrobial and antiviral compounds. Methods for determining the antiviral activity of fabrics are reported in the International Standards Organization (ISO) 18184 (2019) guidelines. Three different fabric samples treated with silver derivate, copper derivative and a not treated cotton fabric used as control were examined and put in contact with a suspension of feline coronavirus (FCoV). After 2 h of incubation a significant decrease of viral titer, as high as 3.25 log10 Tissue Culture Infectious Dose (TCID)

Identifiants

pubmed: 34118297
pii: S0166-0934(21)00153-1
doi: 10.1016/j.jviromet.2021.114214
pmc: PMC8189731
pii:
doi:

Substances chimiques

Antiviral Agents 0
Silver 3M4G523W1G
Copper 789U1901C5

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114214

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

J Feline Med Surg. 2019 Apr;21(4):271-281
pubmed: 30755068
ACS Appl Mater Interfaces. 2020 Aug 5;12(31):34723-34727
pubmed: 32657566
Infez Med. 2020 Mar 1;28(1):3-5
pubmed: 32009128
Biomed J. 2020 Aug;43(4):368-374
pubmed: 32563698
J Feline Med Surg. 2018 Apr;20(4):378-392
pubmed: 28901812
Appl Biochem Biotechnol. 2017 Mar;181(3):1155-1166
pubmed: 27734286
Environ Int. 2020 Jun;139:105730
pubmed: 32294574
J Hosp Infect. 2020 Mar;104(3):246-251
pubmed: 32035997
J Colloid Interface Sci. 2016 Jan 1;461:369-375
pubmed: 26414419
Drug Discov Today. 2020 Apr;25(4):668-688
pubmed: 32006468

Auteurs

Michele Camero (M)

Department of Veterinary Medicine, University of Bari, Valenzano, Italy.

Gianvito Lanave (G)

Department of Veterinary Medicine, University of Bari, Valenzano, Italy. Electronic address: gianvito.lanave@uniba.it.

Cristiana Catella (C)

Department of Veterinary Medicine, University of Bari, Valenzano, Italy.

Maria Stella Lucente (MS)

Department of Veterinary Medicine, University of Bari, Valenzano, Italy.

Nicola Decaro (N)

Department of Veterinary Medicine, University of Bari, Valenzano, Italy.

Vito Martella (V)

Department of Veterinary Medicine, University of Bari, Valenzano, Italy.

Canio Buonavoglia (C)

Department of Veterinary Medicine, University of Bari, Valenzano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH